Reaction mass of (2S)-2-[(4R)-2-oxo-4-propylpyrrolidin-1-yl]butanamide and (2S)-2-[(4S)-2-oxo-4-propylpyrrolidin-1-yl]butanamide

Endpoint summary

Description of key information

Base on the results of an LLNA conducted according to OECD/EC guidelines and GLP principles, the test substance was considered to be a non-sensitiser under the conditions of the test.

Key value for chemical safety assessment

Skin sensitisation

Link to relevant study records

Reference

Endpoint:

skin sensitisation: in vivo (LLNA)

Type of information:

experimental study

Adequacy of study:

key study

Study period:

9 October 2006 - 7 November 2006

Reliability:

1 (reliable without restriction)

Rationale for reliability incl. deficiencies:

guideline study

Qualifier:

according to guideline

Guideline:

OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)

Deviations:

no

Qualifier:

according to guideline

Guideline:

EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay)

Deviations:

no

GLP compliance:

yes (incl. QA statement)

Type of study:

mouse local lymph node assay (LLNA)

Species:

mouse

Strain:

CBA

Sex:

female

Details on test animals and environmental conditions:

TEST ANIMALS
- Source: B & K Universal Ltd, Hull, UK
- Strain: CBA/Ca (CBA/CaBkl)
- Age at study initiation: eight to twelve weeks old
- Weight at study initiation: 15 to 23 g
- Housing: individually housed in suspended solid-floor polypropylene cages furnished with softwood woodflakes
- Diet (e.g. ad libitum): ad libitum
- Water (e.g. ad libitum): ad libitum
- Acclimation period: at least 5 days

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19-25
- Humidity (%): 30-70
- Air changes (per hr): ca. 15
- Photoperiod (hrs dark / hrs light): 12/12

Vehicle:

dimethylformamide

Concentration:

50%, 25% or 10% (w/w) in vehicle

No. of animals per dose:

4

Details on study design:

RANGE FINDING TESTS:
- Compound solubility: butanone and acetone/olive oil (4:1) not suitable for dosing at 50% concentration
- Irritation: daily (for 3 days) application of 25 µl of test material at 50% w/w in vehicle: no signs
- Lymph node proliferation response: not applicable

MAIN STUDY
ANIMAL ASSIGNMENT AND TREATMENT
- Name of test method:
- Criteria used to consider a positive response: The test material will be regarded as a sensitiser if at least one concentration of the test material results in a threefold or greater increase in 3HTdR incorporation compared to control values. Any test material failing to produce a threefold or greater increase in 3HTdR incorporation will be classified as a "non-sensitiser".

TREATMENT PREPARATION AND ADMINISTRATION: The mice were treated by daily application of 25 μl of the appropriate concentration of the test material to the dorsal surface of each ear for three consecutive days (Days 1, 2, 3). The test material formulation was administered using an automatic
micropipette and spread over the dorsal surface of the ear using the tip of the pipette. A further group of four mice received the vehicle alone in the same manner. Five days following the first topical application of the test material (Day 6) all mice were injected via the tail vein with 250 μl of phosphate buffered saline (PBS) containing 3Hmethyl thymidine (3HTdR: 80 μCi/ml, specific activity 2.0 Ci/mmol, GE Healthcare UK Ltd) giving a total of 20 μCi to each mouse.

Positive control substance(s):

hexyl cinnamic aldehyde (CAS No 101-86-0)

Positive control results:

The Stimulation Index (SI) expressed as the mean radioactive incorporation for each treatment group divided by the mean radioactive incorporation of the vehicle control group are as follows: 2.81 at 5% (v/v), 4.20 at 10% (v/v) and 13.15 at 25% (v/v). α-Hexylcinnamaldehyde, Tech, 85% was considered to be a sensitiser under the conditions of the test.

Key result

Parameter:

SI

Value:

0.81

Test group / Remarks:

10%

Key result

Parameter:

SI

Value:

0.81

Test group / Remarks:

25%

Key result

Parameter:

SI

Value:

1.22

Test group / Remarks:

50%

Cellular proliferation data / Observations:

The disintegrations per minute (DPM) were 6447, 5221, 5237 and 7855 for respectively the control grup and groups dosed at 10%, 25% and 50%.

There were no deaths. No signs of systemic toxicity were noted in the test or control animals during the test. White residual test material on the ears was noted, post dosing on days 1 to 3, on animals treated with the test material at a concentration of 50% w/w. Body weight changes of the test animals between day 1 and day 6 were comparable to those observed in the corresponding control group animals over the same period.

Interpretation of results:

GHS criteria not met

Conclusions:

Base on the results of an LLNA conducted according to OECD/EC guidelines and GLP principles, the test substance was considered to be a non-sensitiser under the conditions of the test.

Endpoint conclusion

Endpoint conclusion:

no adverse effect observed (not sensitising)